Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3–4 nasopharyngeal carcinoma

References

• PengGWangTYangKYA prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinomaRadiother Oncol2012104328629322995588
   PubMed Web of Science ®Google Scholar
• LeeAWNgWTChanLLEvolution of treatment for nasopharyngeal cancer – success and setback in the intensity-modulated radiotherapy eraRadiother Oncol2014110337738424630534
   PubMedGoogle Scholar
• NgWTLeeMCChangATThe impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRTOral Oncol201450550651224529762
   PubMed Web of Science ®Google Scholar
• LeeAWMaBBNgWTChanATManagement of nasopharyngeal carcinoma: current practice and future perspectiveJ Clin Oncol201533293356336426351355
   PubMed Web of Science ®Google Scholar
• LeeAWLauKYHungWMPotential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinomaRadiother Oncol200887220421018329742
   PubMed Web of Science ®Google Scholar
• LorchJHGoloubevaOHaddadRITAX 324 Study GroupInduction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trialLancet Oncol201112215315921233014
   PubMed Web of Science ®Google Scholar
• OuDBlanchardPEl KhouryCInduction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinomaOral Oncol20166211412127865364
   PubMed Web of Science ®Google Scholar
• PengHChenLLiWFTumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a secondary analysis of a randomized phase 3 clinical trialCancer201712391643165228001301
   PubMed Web of Science ®Google Scholar
• WangHMLinCYHsiehCHInduction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancerJ Formos Med Assoc2017116318519227133181
   PubMed Web of Science ®Google Scholar
• LinSPanJHanLUpdate report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal marginRadiother Oncol2014110338538924560755
   PubMed Web of Science ®Google Scholar
• DuCYingHZhouJHuCZhangYExperience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinomaInt J Clin Oncol201318346447122527846
   PubMedGoogle Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar
• TrottiAColevasADSetserACTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSemin Radiat Oncol200313317618112903007
   PubMed Web of Science ®Google Scholar
• CoxJDStetzJPajakTFToxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Int J Radiat Oncol Biol Phys1995315134113467713792
   PubMed Web of Science ®Google Scholar
• LeeAWMNgWTChanOSHSzeHCKIf concurrent–adjuvant chemoradiotherapy is beneficial for locoregionally advanced nasopharyngeal carcinoma, would changing the sequence to induction–concurrent achieve better outcome?J Radiat Oncol201212107115
   Google Scholar
• SunYLiWFChenNYInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trialLancet Oncol201617111509152027686945
   PubMed Web of Science ®Google Scholar
• NiuXChangXGaoYHuCKongLUsing neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissueRadiat Oncol2013822624083351
   PubMedGoogle Scholar
• WuFWangRLuHConcurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical studyRadiother Oncol2014112110611124933452
   PubMedGoogle Scholar
• MaoYPYinWJGuoRDosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapyChin J Cancer201534518919726058563
   PubMedGoogle Scholar
• CaoCNLuoJWGaoLUpdate report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: an analysis of survival and treatment toxicitiesOral Oncol201551219019425434585
   PubMed Web of Science ®Google Scholar
• SunXSuSChenCLong-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicitiesRadiother Oncol2014110339840324231245
   PubMed Web of Science ®Google Scholar
• HeYWangYShenLPrognostic value of the distance between the primary tumor and brainstem in the patients with locally advanced nasopharyngeal carcinomaBMC Cancer20161611426884234
   PubMed Web of Science ®Google Scholar
• XuTLiuYDouSLiFGuanXZhuGWeekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: results of a randomized phase II studyOral Oncol201551987587926163437
   PubMedGoogle Scholar
• BossiPOrlandiEBergaminiCDocetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancerAnn Oncol201122112495250021398385
   PubMed Web of Science ®Google Scholar
• ZhouXOuXXuTEffect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control studyInt J Radiat Oncol Biol Phys201490226126925066214
   PubMed Web of Science ®Google Scholar
• BakstRLLeeNPfisterDGHypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trialInt J Radiat Oncol Biol Phys201180114815320605352
   PubMed Web of Science ®Google Scholar
• WangXSYingHMHeXYZhouZRWuYRHuCSTreatment of cerebral radiation necrosis with nerve growth factor: a prospective, randomized, controlled phase II studyRadiother Oncol20161201697527181260
   PubMedGoogle Scholar